Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Lontchi-Yimagou E, Sobngwi E, Matsha TE, et al
Always consult a professional before starting supplements
This consultation helps us create a tailored treatment plan
A triple receptor agonist peptide targeting GLP-1, GIP, and glucagon pathways, studied for multi-receptor signaling mechanisms and metabolic pathway interactions in controlled laboratory settings
It contains the active ingredient Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist
Semaglutide is a GLP-1 receptor agonist already approved separately as Ozempic, Wegovy, and Rybelsus depending on formulation and indication
US$ 29.21
US$ 23.64
.png)
US$ 29.75
US$ 29.14
